Using a speaking valve and transtracheal end‑expiratory pressure to predict upper airway openness

Speaking Valves With Transtracheal End-expiratory Pressure Measurement Predicts Upper Airway Patency in Prolonged Tracheostomy Patients: A Multicenter, Prospective Study

Not applicable Interventional Capital Medical University · NCT07107243

This trial tests whether using a speaking valve together with a transtracheal end‑expiratory pressure (TTPEE) measurement can tell if the upper airway is open in people with prolonged tracheostomies.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment300 (estimated)
Ages18 Years and up
SexAll
SponsorCapital Medical University Academic / other
Locations5 sites (Hunan, Hunan and 4 other locations)
Trial IDNCT07107243 on ClinicalTrials.gov

What this trial studies

This multicenter interventional trial applies a bedside, noninvasive method combining a speaking valve (SV) with transtracheal end‑expiratory pressure (TTPEE) measurement to predict upper airway patency in prolonged tracheostomy patients. Eligible participants are those weaned from the ventilator for more than 48 hours, hemodynamically stable, without sepsis or organ failure, and with PCO2 below 60 mmHg; bronchoscopy may be used as a comparator when clinically indicated. The protocol excludes patients with known severe upper airway obstruction, laryngopharyngeal trauma, inability to tolerate cuff deflation, or prior endoscopic airway assessment. Data will be collected at three Chinese rehabilitation hospitals to determine feasibility and diagnostic accuracy for guiding decannulation decisions.

Who should consider this trial

Good fit: Ideal candidates are prolonged tracheostomy patients who have been off the ventilator for more than 48 hours, are stable without sepsis or organ failure, have PCO2 <60 mmHg, and can tolerate cuff deflation.

Not a fit: Patients with known severe upper airway obstruction, inability to tolerate cuff deflation, laryngopharyngeal trauma, active sepsis or major organ failure, or those whose airway has already been assessed by endoscopy are unlikely to benefit from this approach.

Why it matters

Potential benefit: If successful, this method could provide a simple bedside test to help identify patients who can safely have their tracheostomy decannulated.

How similar studies have performed: Speaking valves and pressure measurements have been used previously to infer airway patency, but combining SV with transtracheal end‑expiratory pressure measurement is relatively novel and not yet widely validated.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Weaned from ventilator more than 48 hours
* No any organ failure
* No sepsis
* Stable heart rate and blood pressure
* Lung infection under control
* PCO2\<60mmHg
* Patient and family sign informed consent form

Exclusion Criteria:

* Serious dysfunction of vital organs
* Inability to tolerate cuff deflation
* Laryngopharyngeal trauma
* Known severe upper airway obstruction before referrer to our department
* Endoscopy(bronchoscopy or laryngoscopy) has been performed and the condition of the upper airway has known

Where this trial is running

Hunan, Hunan and 4 other locations

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Tracheostomytranstracheal end-expiratory pressurespeaking valveupper airwayprolonged tracheostomized patients
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.